46033 research outputs found
Sort by
Nature\u27s Relief: Efficacy of Plant-Based Therapies vs. Placebo in Easing Vasomotor Menopausal Symptoms
Background: Vasomotor symptoms (VMS) impact the lives of menopausal women. Plant-based therapies are frequently used as alternatives to hormonal therapy, warranting evaluation of their effectiveness.
Purpose: This literature review evaluates the efficacy of plant-based therapies in alleviating VMS during menopause and compares their effectiveness to placebo treatment.
Methods: A literature review was conducted utilizing PubMed and Cumulative Index to Nursing and Allied Health Literature (CINAHL).
Results: The review includes a synthesis of 16 primary studies, highlighting five therapies: black cohosh, soy, red clover, evening primrose, and combination therapy in managing VMS. Soy consistently reduces VMS. Black cohosh, red clover, evening primrose, and combination therapy demonstrate some efficacy, however results are inconsistent.
Implications for practice: Soy effectively manages VMS and can be incorporated into the diet or through supplementation. Combination therapy may be helpful with added synergistic benefits but considered secondary to soy. Black cohosh, red clover, and evening primrose have mixed results. Healthcare providers should utilize a personalized approach when recommending plant- based therapies. Additional large-scale randomized controlled trials are necessary to confirm the efficacy of plant-based therapies and help determine safety and optimal dosing recommendations
Supplement to A number talk informed by the socio-ecological
A group of fourth graders demonstrate strategies for addition, explaining the different ways they added four objects
B-17 Henderson Field Guadalcanal
A grounded Boeing B-17 Flying Fortress in Henderson Field, Guadalcanal. The title of the photograph came from the original photographer\u27s album.https://commons.und.edu/infantry-photos/1074/thumbnail.jp
Don
A group of troops ride on the back of a military vehicle. Don is labeled as the title, though he is not pinpointed in the photograph precisely. Title taken from photographer\u27s original album.https://commons.und.edu/infantry-photos/1146/thumbnail.jp
Spring 2025
Spring 2025 issue of The University of North Dakota Alumni Magazine. 60 pages
Volume 108, Number 2https://commons.und.edu/und-alumni-review/1704/thumbnail.jp
Monoclonal Antibody Therapy Versus Oral Immunotherapy in Food Allergies
Food allergies are classified as an immune hyperreaction that leads to various symptoms that can range from mild to severe and even result in death. Often, management of food allergies includes avoidance of triggering substances or rescue treatment after exposure has occurred. This literature review aims to examine preventative management options for food allergies, including oral immunotherapy, and recent medications, including monoclonal antibodies. The databases searched for this literature review include PubMed, Embase, and Google Scholar. Additional references were also selected from reference lists in those studies as they pertained. This review explores the success in reaching desensitization following treatment with oral immunotherapy (OIT) or monoclonal antibodies (MAB) or combinations of the two treatments and the potential benefits and risks of each treatment option in preventing food allergic reactions. The literature has shown that depending on patient’s allergies and immunoglobin E (IgE) levels, they may benefit more from one treatment over the other. Studies have shown that individuals with multiple food allergies have a higher success at reaching allergen desensitization with MAB as the medication can desensitize someone to multiple allergens simultaneously. When looking at baseline IgE levels, higher levels have been shown to benefit more and have a higher success rate of desensitization from a combination of OIT and MAB, as they are more at risk of developing reactions. In comparison, individuals with a lower baseline IgE level had a higher success rate of desensitization with OIT alone. Current guidelines in the United States still focus on food allergen avoidance, but newer therapies have shown promising outcomes in developing food desensitization and preventing allergic reactions
Tunka Oyate
A large, contemporary piece of ledger art featuring a warrior figure riding a horse, a figure dancing, a large fist grabbing an orange circle, on the right side there are lines of orange circles in lines of four. There is a large and smaller black hand print across the orange circles. The number four is features repeatedly across the piece. The words TUNKA OYATE are on the right side below the handprints.https://commons.und.edu/native-art/1139/thumbnail.jp
Familiarity moderates education level of stigma for professional efficacy of treating mental illness
Background: About one in five adults in the United States experience any mental illness (AMI) whereas 14.2 million experience serious mental illness (SMI). The perception of stigma among these individuals can be associated with care seeking behavior and treatment adherence.
Purpose: Two factors that mitigate stigma are familiarity with someone experiencing AMI/SMI and general level of education. Heretofore, these factors have not been tested together to determine if familiarity moderates the relation between level of education and stigma of professional efficacy for treating mental illness.
Methods: In fall 2020, an online survey in the state of Utah measured 1,300 adults’ perceptions of stigma for AMI/SMI using a validated instrument. Data were analyzed using logistic regression.
Results: Results indicated that familiarity (i.e., self or immediate family member versus other person) moderated level of education for stigma of professional efficacy for treatment of AMI but not SMI.
Discussion: Participants viewed the professional efficacy of treating AMI and SMI differently. These findings have implications for educational interventions designed to mitigate public stigma for professional efficacy of treating mental illness.
Translation to Health Education Practice: Emphasizes the National Commission for Health Education Credentialing Inc. assessment of needs and capacity, and evaluation and research competencies
Safety and Efficacy of Combined Glucosamine and Chondroitin Supplementation in Osteoarthritis
According to the CDC, over 30 million adults in the United States have osteoarthritis, many of whom experience pain, stiffness, and swelling that hinder daily activities. Typical treatment consists of nonsteroidal anti-inflammatory drugs, which are associated with gastrointestinal, renal, and cardiovascular risks. This literature review examines key research on glucosamine and chondroitin supplementation to provide a comprehensive understanding of its impact on adults with osteoarthritis. A literature search was conducted using the electronic databases PubMed, Embase, and Google Scholar. Keywords and MeSH terms were used to identify studies discussing the combination of glucosamine and chondroitin as a potential alternative, effective, and safe treatment for osteoarthritis. The findings suggest that while glucosamine and chondroitin supplementation is safe, there is currently no convincing evidence that it reduces pain or improves physical function in adults with osteoarthritis